Edgewise Therapeutics

Check out our video talking about why we are leaders in muscle disease science. We're excited to be part of the Biophysical Society's 60th Annual Meeting. Link to the full video here:  https://lnkd.in/ejD8KDQE

Mark your calendars! Becker Education and Engagement Day (BEED) is returning on September 27! Be on the lookout for all the exciting details! #BeckerMuscularDystrophy #BeckerMD

At our recent annual employee off-site meeting, we had the privilege of hearing directly from those who live with diseases we work in. At Edgewise, we believe it’s essential to bring their voices into our decision-making, ensuring their experiences and challenges are always front and center. By connecting with the community through these individual conversations, we’re able to hear their personal stories, guiding us to better understand the challenges faced and where support is needed most. Our patient panel was a powerful reminder of the “why” for what we do. We’re proud to be part of these conversations and do our part in making a difference in their lives. #PatientVoice #HCM #Becker #Duchenne

The Edgewise team is heading to Chicago to attend the the American College of Cardiology (ACC) Scientific Session! We look forward to connecting with cardiovascular experts, learning from our peers and discovering the latest advancements in heart health. #ACC25 #HCM

We’re looking for new teammates! Do you share our passion for drug discovery? Join us on our mission to unearth new medicines that improve the lives of those living with serious muscle disease. At Edgewise Therapeutics, we offer a scientifically rigorous and collaborative environment where every team member brings decades of deep knowledge and dedication to muscle research. Add muscle to your career–apply today: https://lnkd.in/e77EfAia

We’re excited to announce the launch of our new HCP Becker site! Designed as a comprehensive source for disease background, patient support tools, and recommendations from management guidelines, the site empowers healthcare professionals with the resources they need to optimize patient care. At Edgewise Therapeutics, patients are at the core of our mission and we remain committed to improving the lives of those living with serious muscle disease. See for yourself–visit https://lnkd.in/eGnRHB-K

Limited awareness and understanding of Becker muscular dystrophy may contribute to delayed diagnosis or misdiagnosis, as well as costly and unnecessary tests that can be overwhelming for those looking for answers. Recognizing the signs and symptoms early is essential for people affected by serious muscle disease. We’re dedicated to amplifying the patient voice and improving standards of care. #BeckerMuscularDystrophy #BeckerMD

Meet Nicholas Mastrandrea, PhD, our Director of Field Medical Affairs. Nick collaborates with clinicians who care for those living with Duchenne and Becker muscular dystrophies. He is deeply motivated and inspired by the community's resilience, driving his dedication to advancing care and making a meaningful difference for patients in need. #MuscularDystrophy #Duchenne #BeckerMD

We're looking forward to seeing you at the #MDAConference! Join us for our Lunch Forum, "Spotlight on Becker muscular dystrophy: Understanding the lived experience of Becker and clinical advancements with a novel agent," with patient advocate Michael Voto Jr. and medical expert Prof. Craig McDonald. Tune in for this meaningful discussion on March 18 at 12pm CST. Don't forget to stop by our booth #502 to learn more about contraction-induced muscle injury, the latest in muscle disease science and say hi to our team! #MDAConference #EdgewiseTherapeutics

Muscles move us to push further. To think deeper. To see differently. We believe that muscles are more than strength. We’re proud to be part of shaping a new era of muscle-focused medicines with patients at the center. At Edgewise we take pride in asking new questions–seeking new answers for therapeutic needs. We’re committed to discovering new medicines for patients and families affected by serious muscle and cardiovascular disease. Learn more at: https://lnkd.in/efsdBn7k #CompanyCulture #BeckerMuscularDystrophy #Duchenne #HCM